Company Search:
Advanced Search
Sponsored Links
Noxopharm Ltd Company Snapshot
Noxopharm Ltd operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Noxopharm Ltd with three other companies in this sector in AUSTRALIA : Acrux Ltd (2021 sales of 4.79 million Australian Dollars [US$3.47 million] of which 100% was Developing and Commercialising products ), Adalta Ltd (3.99 million Australian Dollars [US$2.89 million] of which 100% was Pharmaceutical), and Regeneus Ltd (7.07 million Australian Dollars [US$5.12 million] ).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Noxopharm Ltd
  Stock Performance Chart for Noxopharm Ltd
  Stock Data: Recent Stock Performance:
  Current Price (9/24/2021): .57
(Figures in Australian Dollars)
1 Week 9.7%   13 Weeks -1.7%  
4 Weeks -8.9%   52 Weeks 37.8%  
Noxopharm Ltd Key Data:
  Ticker: NOX Country: Australia
  Exchanges: ASX Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2021 Sales 5,747,723
(Year Ending Jan 2022).
Employees: N/A
  Currency: Australian Dollars Market Cap: 162,845,276
  Fiscal Yr Ends: June Shares Outstanding: 288,221,727
  Share Type: Ordinary Closely Held Shares: 102,318,663
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.